Consumer prices in October increased by 0.4%, exceeding the expected 0.3%, largely due to delayed effects of September's energy prices on food and transport. The Federal Reserve, with less forward guidance, risks raising interest rates in an economy that is already cooling, which could be a policy mistake. Meanwhile, a less lagging inflation gauge, Truflation, rose sharply in September but has started to decline as oil prices fall. The analyst expects AI-driven productivity gains to push the neutral interest rate to around 3.5%-3.8%, slightly above the Fed's current estimate but below the cycle's peak. Despite these factors, US equities remain attractive at about 18 times forward earnings, supporting a strong buy stance with plans to add on market dips.
The CPI report and Fed policy risks provide context for Pluang's market snapshot as of Nov 11, 2026 18:11 WIB: Out of 150 US stocks, 88 rose and 60 fell. Notable movers include AMAT at USD 395.15 (+6.07%), TSM at USD 418.13 (+5.46%), and UMC at USD 15.84 (+5.32%). Typical hold times vary from 44 to 114 days, with mixed Pluang order activity percentages.
NRx Pharmaceuticals has begun selling a new preservative-free ketamine made in the U.S., addressing a shortage that has persisted since 2018. This ketamine uses innovative blow-fill-seal technology, eliminating the preservative benzethonium chloride,...
FLSmidth & Co. A/S announced its financial calendar for 2027, including key dates for the annual report, interim financial reports, and the annual general meeting. The company emphasizes its commitment to sustainability with its MissionZero goal to a...
Dimensional Fund Advisors Ltd. has filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc, totaling 12,054,886 shares as of November 10, 2026. This disclosure is part of regulatory requirements under the Takeover Code, indicatin...
Dimensional Fund Advisors Ltd. has filed a disclosure showing it holds a 1.61% stake in DCC Energy plc's ordinary shares as of November 10, 2026. The firm sold 42,998 shares recently at a price of £64.5585 each. This disclosure is part of regulatory ...
Novo Nordisk has committed $200 million to the World Diabetes Foundation for 2027–2036 to enhance diabetes prevention and care in low- and middle-income countries. This funding aims to improve equitable access to diabetes services in underserved comm...
